Page last updated: 2024-11-08

epsilon n-dimethyllysine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N(6),N(6)-dimethyl-L-lysine : An L-lysine derivative comprising L-lysine having two methyl substituents attached to the side-chain amino group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID193344
CHEBI ID43997
SCHEMBL ID358975
MeSH IDM0070947

Synonyms (29)

Synonym
epsilon n-dimethyllysine
DB03362
n-dimethyl-lysine
MLY ,
nepsilon-dimethyl-l-lysine hydrochloride
n(6),n(6)-dimethyl-l-lysine
n6,n6-dimethyl-l-lysine
2259-86-1
(2s)-2-amino-6-(dimethylamino)hexanoic acid
n(epsilon),n(epsilon)-dimethyllysine
CHEBI:43997
n(epsilon),n(epsilon)-dimethyl-l-lysine
n(epsilon)-dimethyllysine
n(6),n(6)-dimethyllysine
(s)-2-amino-6-dimethylaminohexanoic acid
lys(me2)
n(epsilon)-dimethyl-l-lysine
n,n-dimethyl lysine
lys(me)2
XXEWFEBMSGLYBY-ZETCQYMHSA-N
l-lysine, n6,n6-dimethyl-
SCHEMBL358975
n6,n6-dimethyllysine
n'-dimethyl-l-lysine
n~6~,n~6~-dimethyl-l-lysine
n~6~,n~6~-dimethyllysine
DTXSID60945241
Q27104521
EN300-1300752
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
L-lysine derivativeA proteinogenic amino acid derivative resulting from reaction of L-lysine at the amino group or the carboxy group, or from the replacement of any hydrogen of L-lysine by a heteroatom.
non-proteinogenic L-alpha-amino acidAny L-alpha-amino acid which is not a member of the group of 23 proteinogenic amino acids.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (57.14)18.7374
1990's2 (14.29)18.2507
2000's3 (21.43)29.6817
2010's1 (7.14)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.70

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.70 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.40 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.70)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]